Advisornet Financial’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-415
| Closed | -$9.08K | – | 2210 |
|
|
2025
Q1 | $9.08K | Sell |
415
-26
| -6% | -$569 | ﹤0.01% | 1424 |
|
|
2024
Q4 | $14.1K | Buy |
441
+291
| +194% | +$9.29K | ﹤0.01% | 1217 |
|
|
2024
Q3 | $4.33K | Sell |
150
-80
| -35% | -$2.31K | ﹤0.01% | 1594 |
|
|
2024
Q2 | $8.82K | Hold |
230
| – | – | ﹤0.01% | 1334 |
|
|
2024
Q1 | $13.5K | Sell |
230
-20
| -8% | -$1.18K | ﹤0.01% | 1195 |
|
|
2023
Q4 | $15K | Sell |
250
-2
| -0.8% | -$120 | ﹤0.01% | 1187 |
|
|
2023
Q3 | $9.59K | Buy |
252
+22
| +10% | +$837 | ﹤0.01% | 1254 |
|
|
2023
Q2 | $21K | Sell |
230
-40
| -15% | -$3.64K | ﹤0.01% | 1076 |
|
|
2023
Q1 | $17.8K | Buy |
+270
| New | +$17.8K | ﹤0.01% | 1117 |
|